4.5 Article

Clinical impact of the accelerate PhenoTest & REG; BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study

Amira A. Bhalodi et al.

Summary: The study demonstrates that using the Accelerate PhenoTest BC Kit (AXDX) for testing patients with bloodstream infections leads to significant reductions in time to optimal therapy, first antimicrobial modification, and time to antimicrobial deescalation.

CLINICAL INFECTIOUS DISEASES (2022)

Article Microbiology

Evaluation of the Performance and Clinical Impact of a Rapid Phenotypic Susceptibility Testing Method Directly from Positive Blood Culture at a Pediatric Hospital

Thao T. Truong et al.

Summary: Bloodstream infection is a serious medical emergency that requires timely administration of appropriate antibiotics. Conventional antimicrobial susceptibility testing methods can take several days, but the Accelerate Pheno Blood Culture panel offers a rapid testing option that can provide results within a few hours. This study evaluated the effectiveness of Pheno in pediatric patients with bloodstream infections and found that it accurately identified susceptibility and allowed for faster optimization of therapy.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Article Immunology

Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN

Ritu Banerjee et al.

Summary: The study demonstrated that rapid organism identification and phenotypic AST can lead to faster antibiotic therapy adjustments for patients with gram-negative bloodstream infections (BSIs), ultimately improving treatment outcomes.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients

Ryan K. Dare et al.

Summary: The implementation of AXDX significantly improved patient outcomes, including reduced length of stay, increased frequency of achieving optimal therapy, faster time to optimal therapy, and shorter total days of antimicrobial therapy. The results indicate that AXDX can be integrated into healthcare systems with an active antimicrobial stewardship program without the need for real-time notification.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia

Thomas L. Walsh et al.

Summary: A study was conducted to compare the management of non-critically ill patients with GNB BSI before and after the implementation of a bundled initiative. The initiative included clinical decision algorithm dissemination, ACC testing on all GNB isolated from blood cultures, real-time communication of results to ASP, and prospective audit with feedback by ASP. The implementation led to improvements in time from Gram stain to AST, time to definitive therapy, total duration of antibiotic therapy, and hospital length of stay without increasing readmission rates.

INFECTION (2021)

Article Microbiology

Evaluation of the Accelerate Pheno System for Rapid Identification and Antimicrobial Susceptibility Testing of Positive Blood Culture Bottles Inoculated with Primary Sterile Specimens from Patients with Suspected Severe Infections

V Chapot et al.

Summary: The study evaluated the performance of the Accelerate Pheno system for identification and AST from positive blood culture bottles inoculated with primary sterile specimens, showing that the system can accelerate pathogen identification and antimicrobial susceptibility testing, especially for hospitals without on-site microbiology laboratories. However, inclusion of nonblood specimens with a high likelihood of polymicrobial infections may lead to inferior performance.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Microbiology

Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia

Faith Babowicz et al.

Summary: The study evaluated the impact of Accelerate Pheno and BacT/Alert Virtuo systems on outcomes in patients with sepsis and concurrent Gram-negative bacteremia. Post-implementation, there were significantly shorter times for Gram stain and susceptibility results, improvements in narrow-spectrum Gram-negative therapy initiation at 72 hours, 30-day inpatient mortality, and sepsis resolution. Overall, the implementation of these systems improved microbiology laboratory processes, antibiotic utilization processes, and clinical outcomes, supporting the use of rapid diagnostics in sepsis with Gram-negative bacteremia.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Infectious Diseases

Effective implementation of the Accelerate Pheno™ system for positive blood cultures

Romney Humphries et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Infectious Diseases

Direct antimicrobial susceptibility testing of positive blood cultures: a comparison of the Accelerate Pheno™ and VITEK® 2 systems

Jack G. Schneider et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)

Article Infectious Diseases

Performance of the Accelerate Diagnostics Pheno™ system with resin-containing BacT/ALERT® Plus blood culture bottles

Kimberly F. Starr et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)

Article Infectious Diseases

Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections

Ghislaine Descours et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)

Article Microbiology

Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers

Joseph D. Lutgring et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2018)